Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02787694 · ClinicalTrials.gov registry record · NA

Machines Assisting Recovery From Stroke

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT02787694: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT02787694 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02787694, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

Locomotor disability remains a major obstacle to community function in stroke survivors. This disability is best characterized by the reduced gait speed and enhanced risk of falls that is observed in the majority of stroke survivors. Current robotic systems have focused on repetitive stepping in constrained, less-challenging environments than overground training and have failed to produce results that can justify their use. In contrast to this approach, this study will use a combinatorial approach on a moving platform (KineAssist-Mobility Activity Center) that simulates and enhances the challenges of overground training. We focus on five critical factors that contribute to reduced speed and fall risk during mobility activities: 1) lower limb weakness; 2) slow lower limb movements; 3) reduced balance; 4) reduced ability to respond to challenges during walking; and 5) reduced aerobic capacity. The end product of this study is to develop a comprehensive and standardized system for assessing and prescribing specific training modalities that can be used by clinicians to help stroke survivors who are limited by slow walking speed and high fall risk, and can improve participation in mobility activities.

Primary Outcome

Overground 10 meter walk test consisting of three trials administered at baseline (pre-intervention) and at 10 weeks (post-intervention).

Interventions

  • DEVICE treadmill
  • OTHER Factor Targeted Walking Training

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2013-06
Est. Completion 2017-10
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02787694 record still lists

NCT02787694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which treadmill is the first listed.

NCT02787694 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02787694 about?

NCT02787694 is a clinical study titled "Machines Assisting Recovery From Stroke". Locomotor disability remains a major obstacle to community function in stroke survivors. This disability is best characterized by the reduced gait speed and enhanced risk of falls that is observed in the majority of stroke survivors. Current robotic systems have focused on repetitive stepping in con...

What is the current status of trial NCT02787694?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-06. Estimated completion is 2017-10.

What interventions are being tested in trial NCT02787694?

The interventions under investigation include: treadmill (DEVICE), Factor Targeted Walking Training (OTHER).

Who is sponsoring clinical trial NCT02787694?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02787694's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02787694, the US trial registry maintained by the National Library of Medicine. NCT02787694 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.